Performance of free prostate-specific antigen ratio in differentiating between prostatic cancer and benign prostatic lesions at a referral hospital in South Africa
Background: Prostate cancer is a leading cause of morbidity and mortality in our male population, thus screening initiatives will help to improve outcomes. The current screening marker, total prostate-specific antigen (PSA), is not prostate cancer specific. The development of percentage free PSA (%F...
Saved in:
| Main Authors: | Boitumelo Phiri-Ramongane, Ayeaye Khine |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
AOSIS
2018-08-01
|
| Series: | South African Family Practice |
| Subjects: | |
| Online Access: | https://safpj.co.za/index.php/safpj/article/view/4889 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Benign prostatic hyperplasia and prostate-specific antigen
by: Pejčić Tomislav, et al.
Published: (2015-01-01) -
Immunohistochemical expression of androgen receptors in prostate carcinoma and benign prostatic hyperplasia
by: Trivunić-Dajko Sandra, et al.
Published: (2020-01-01) -
Advanced prostatic carcinomas with low serum levels of prostate-specific antigen
by: Cerović Snežana J., et al.
Published: (2002-01-01) -
Characterisation of Multiparametric Magnetic Resonance Imaging of the Prostate in Younger Men with Normal Prostate-specific Antigen Within the PROBASE Study
by: Rouvier Al-Monajjed, et al.
Published: (2025-05-01) -
Optimal use of prostate specific antigen for prostate cancer screening
by: Miočinović Ranko, et al.
Published: (2013-01-01)